Taha Al-Juhaishi to Bortezomib
                            
                            
                                This is a "connection" page, showing publications Taha Al-Juhaishi has written about Bortezomib.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.047
         
        
        
     
 
    
        
        - 
            Real-world long-term outcomes in multiple myeloma with VRD induction, Mel200-conditioned auto-HCT, and lenalidomide maintenance. Leuk Lymphoma. 2022 03; 63(3):710-721.
            
            
                Score: 0.047